Patents Assigned to TIGAR HEALTH, INC.
  • Patent number: 11107565
    Abstract: Systems and methods are provided for providing diabetes patient treatment guidance for a patient in which a biochemical data set is obtained. The biochemical data set comprises test results from a single blood draw of the patient including at least three measurements selected from the set: a high-sensitivity c-reactive protein test, an adiponectin level test, an intact proinsulin level test, an insulin level test, a C-peptide test, a HbA1c test, and an eGFR level test. A demographic data set for the patient is also obtained that comprises the patient's gender and diabetes stage. The biochemical data set and demographic data set is run against one or more rules to determine a first patient therapy pattern. Then, a report is prepared based on an identity of the first therapy patient pattern. The report sets priorities among intervention classes for the patient based on the identity of the first patient pattern.
    Type: Grant
    Filed: November 2, 2018
    Date of Patent: August 31, 2021
    Assignee: TIGAR HEALTH, INC.
    Inventors: Robert Maurer, Barry Ginsberg